Emetogenic Potential of Antineoplastic Agents
Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.
Emetogenic potential (high, moderate, low, or minimal risk) of oral and injectable antineoplastic agents.
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
Significantly increased risk of any cancer and solid tumors; greatest risks seen for lymphoma and sarcoma
A comparative list of biosimilars approved by the FDA including their reference products, dosage forms and indications.
FDA-Approved treatment options for individuals with ovarian cancer including dosing.
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Colorectal cancer treatment regimen chart.
FDA-approved oral and injectable treatment options for breast cancer.
Approved prostate cancer drug treatments including formulations and usual dosing.